Invention Grant
- Patent Title: Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
-
Application No.: US17025790Application Date: 2020-09-18
-
Publication No.: US11518772B2Publication Date: 2022-12-06
- Inventor: Jiping Fu , Yan Lou , Yigang He
- Applicant: NiKang Therapeutics, Inc.
- Applicant Address: US DE Wilmington
- Assignee: NiKang Therapeutics, Inc.
- Current Assignee: NiKang Therapeutics, Inc.
- Current Assignee Address: US DE Wilmington
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D519/00
- IPC: C07D519/00 ; A61P35/00 ; A61K31/5383 ; C07D401/14 ; C07D471/10 ; C07D491/107
Abstract:
The present disclosure provides certain fused tricyclic ring derivatives that are Src Homology-2 phosphatase (SHP2) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of SHP2. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Public/Granted literature
- US20210188876A1 FUSED TRICYCLIC RING DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATE INHIBITORS Public/Granted day:2021-06-24
Information query
